These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin. Muff R, Dambacher MA, Perrenoud A, Simon C, Fischer JA. Am J Med; 1990 Aug; 89(2):181-4. PubMed ID: 2382666 [Abstract] [Full Text] [Related]
8. Long-term treatment of Paget's disease of bone with salmon calcitonin. Sturtridge WC, Harrison JE, Wilson DR. Can Med Assoc J; 1977 Nov 05; 117(9):1031-4. PubMed ID: 562231 [Abstract] [Full Text] [Related]
13. [Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins]. Caniggia A, Nuti R, Vattimo A, Galli M, Turchetti V, Franci B, Martorelli T, Righi G. Minerva Med; 1983 Apr 28; 74(18):993-1010. PubMed ID: 6087215 [Abstract] [Full Text] [Related]
14. Treatment of Paget's disease of bone with salmon calcitonin nasal spray. Gagel RF, Logan C, Mallette LE. J Am Geriatr Soc; 1988 Nov 28; 36(11):1010-4. PubMed ID: 3171038 [Abstract] [Full Text] [Related]
15. Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods. Oreopoulos DG, Husdan H, Harrison J, Meema HE, McNeill KG, Murray TM, Ogilvie R, Rapoport A. Can Med Assoc J; 1977 Apr 23; 116(8):851-5. PubMed ID: 856428 [Abstract] [Full Text] [Related]